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Abstract
Background: Our recent clinical observations put into question the routine hormonal therapy for pneumothorax
recurrence prevention, in patients operated for catamenial pneumothorax (CP).
Methods: Retrospective review of the treatment of four women operated for CP in a recent 32-months period.
Results: The four presented patients with CP represent 4.8 % of the overall number of patients operated for
spontaneous pneumothorax and 19 % of women operated for pneumothorax in the same period. In all patients,
typical multiple diaphragm holes existed. The involved part of the diaphragm was removed with diaphragm suture
in three patients, whilst in one patient, a diaphragm placation was done. Endometriosis was histologically confirmed in
two patients. During the follow-up period of 6–43 months, none of the patients underwent a postoperative hormonal
therapy for different reasons, and in none of them the pneumothorax recurrence occurred.
Conclusion: The clinical course of these patients, with the absence of the pneumothorax recurrence despite the
omission of the hormonal treatment, suggests that the appropriateness of the routine hormonal treatment with
gonadotrophin-releasing hormone analogues for 6–12 months, should be reconsidered and re-evaluated in further
studies.
Background
The term „catamenial pneumothorax” (CP) relates to
recurrent spontaneous pneumothorax (SP) in women,
whose onset has some temporal relation with menses,
that is not sharply defined. According to most authors, if
the onset of recurrent SP is within 72 hours after [1], or
within 24 hours before and 72 hours after the onset of
menses [2], the pneumothorax can be classified as
catamenial.
The incidence of this predominantly right-sided disease
has been underestimated for years, reported as not ex-
ceeding 3–6 % of all spontaneous pneumothoraces. Recent
retrospective studies reported CP in up to one third of
ovulating women operated for pneumothorax [3].
The most frequently reported mechanism of CP is a
passage of air through congenital or acquired (secondary
to endometriosis) diaphragmatic defects in a way that air
from the vagina, through the cervix (due to absence of
cervical mucous during menstruation), uterus and fallo-
pian tubes, reaches the peritoneal cavity, and finally the
pleural space through the diaphragmatic defects [4–6].
Diaphragmatic endometrial implants, if present, may
cause diaphragmatic defects due to their cyclical necrosis.
There is a broad consensus that gonadotrophin-releasing
hormone (GnRH) analogue therapy for 6–12 months is
essential for recurrence prevention, owing to the induced
hypogonadotropic hypogonadism and amenorrhea. The
ovarian rest and suppression of ectopic endometrium
activity achieved in that way [7, 8] prevent cyclic hormonal
changes that may cause a pneumothorax.
Our clinical observation that in none of our four pa-
tients a pneumothorax recurrence occurred at follow up,
despite the omission of the hormonal treatment, was the
reason to reconsider the appropriatness of the routine
hormonal therapy in all patients with catamenial
pneumothoraces.* Correspondence: profsubotic@gmail.com
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Methods
In the period between October 2011. and June 2014.
the diagnosis of catamenial and endometriosis-related
pneumothorax was established in four women operated
for recurrent spontaneous pneumothorax. In order to
assess the incidence of this condition, we retrospectively
reviewed hospital charts of all patients hospitally treated
for spontaneous pneumothorax in the same period.
The institutional therapeutic algorythm for SP was a
needle-aspiration in all patients as the initial treatment,
except in patients with tension pneumothorax, spontan-
eous hemopneumothorax or in patients with evident
major adhaesions. In case of the treatment failure, chest
tube insertion and active suction for at least 3–4 days is
the next step. Indications for surgery were more than
two recurrences and impossibility to achieve or maintain
a full lung expansion under active suction after 7-10
days at maximum. In this group of patients, we did not
perform pleurectomy or chemical pleurodesis for recur-
rence prevention.
Surgical treatment of pneumothorax is performed by
VATS. For the presented four patients, surgery was done
through muscle sparing thoracotomy, because of the
need for the diaphragm reconstruction.
After discharge, all operated women underwent regu-
lar gynaecological controls including ultrasonography
and laboratory analyses.
The main clinical characteristics, operative findings,
patohistological reports and postoperative treatment of
all four patients are presented and compared with the
literature data.
Results
In the analysed period, 724 patients were admitted for
SP. There were 591(81.6 %) males and 133(18.4 %)
females, M:F 4.4:1. The right-sided and left-sided pneu-
mothoraces existed in 321(54.3 %) and 263(45.7 %)
patients respectively in males and in 82(61.6 %) and
50(38.4 %) patients respectively in females. Bilateral
pneumothorax existed in 2 males and in one female.
All five patients with spontaneous hemopneumothorax
were males.
In the same period, 82/724(11.3 %) patients (61 men,
21 women) underwent a surgical treatment, either for
more than two recurrences or the impossibility to
achieve or maintain a full lung expansion under the
active chest tube aspiration.
Among the operated patients, pneumothorax was
right-sided in 38(62.3 %) and 16(76.2 %) patients and
left-sided in 23(37.7 %) and 5(23.8 %) patients in men
and women, respectively.
The four presented patients with CP represent 4.8 %
of the overall number of operated patients and 19 % of
the operated women.
The main clinical characteristics of the operated patients
are summarized on Table 1.
Relation with menses; number of SP recurrences
In three patients (No 2, 3 and 4), CP took place within
24–72 h of the menses onset, whilst in patient No 1,
despite characteristic morphology and proven endomet-
riosis, no temporal relation with menses existed. All
patients had a chest pain at the time of pneumothorax
onset, in patients No 1 and 2 associated with dyspnea
and decreased effort tolerance.
The number of SP episodes in the presented patients
was 2–5. In all but one patient a chest tube insertion
was necessary to achieve a lung expansion. Surgery was
indicated because of the impossiility to maintain lung
expansion in one patient (No1), whilst in two patients,
the number of CP recurrences was the indication for
surgery. In the 4th patient, apart from the third CP
episode, surgery was indicated because of the thora-
coscopically confirmed intrathoracic liver herniation
through the diaphragm, radiographically manifested as
Table 1 Patients’ characteristics
Patient 1 Patient 2 Patient 3 Patient 4
Age (years) 33 33 49 37
No of SP episodes before surgery 2 5 5 2
Treatment before the OP Needle aspiration; drainage Needle aspirations Drainage Needle aspiration; drainage
Interval 1st SP episode-OP (months) 4.5 4 26 4.5
Operative finding Diaphragm defects Yes Yes Yes Yes
Lung bullous lesions Yes No Yes No
Lung E. No No No No
PH confirmed endometriosis Yes Yes No No
Hormonal therapy No No No No
Follow up period (months) 24 43 14 6
Pneumothorax recurrence No No No No
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undetermined ovoid opacity within the shadow of the
right hemidiaphragm.
In all operated women, (including patient No 1 with-
out temporal relation to menses), the existence of cata-
menial pneumothorax was anticipated before surgery
(thoracoscopically confirmed in pts. No 2 and 4) and op-
erative procedure planned accordingly.
Operative procedure
In all patients, operative finding was typical for CP, in
form of multiple holest, 1–3 mm in size, in the mem-
branous part of the diaphragm (Figs. 1, 2, 3). In the 1st
patient, such a finding was associated with apical lung
bullous lesion, whilst in the 4th patient, a large dia-
phragm defect with a partial liver protrusion next to the
described cribriform defects existed as well.
In three patients, a partial excision of the diaphragm
was done in a way to include all defects, followed by dir-
ect diaphragm suture (Fig. 4). In the 3rd patient, only a
diaphragm plication was done. In the 1st and 3rd pa-
tients, the aformentioned procedures were associated
with atypic resection of the apical lung zones, whilst in
the 4th patient, a partial resection of the diaphragm pre-
ceeded the liver reposition into the abdomen.
Follow up
None of the patients underwent a postoperative hormo-
nal therapy for different reasons: the first patient wanted
to become pregnant, whilst the second and third patients,
referred to gynaecologist upon discharge, were not sug-
gested to undergo such a treatment. Their gynaecological
status and laboratory analyses were normal, with no
ultrasonographic signs suggestive of endometriosis.
Furthermore, coelioscopy, the only method that could
reliably confirm endometriosis, was not indicated in
these women. In the fourth patient, hormonal therapy
was deemed unnecessary after the thorough exploration
of the subdiaphragmatic region through the diaphragm
defect, not revealing any signs of endometriosis.
Fig. 1 Diaphragm defects (patient 2): insert: removed part of
the diaphragm
Fig. 2 Resected part of the diaphragm (patient 1); arrows:
diaphragm defects
Fig. 3 Rtg-aspect on admission (patent 1)
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During the follow up period of 6–43 months, in none
of the four women recurrence occurred.
Discussion
In the analysed period, the CP incidence of 0.55 % is
slightly lower, but still within the reported range, not ex-
ceeding 3–6 % of all pneumothoraces [9]. On the other
hand, expressed as a percentage of operated women
(19 %), our case series confirms similar literature data,
thus underlying the need for active diagnostic approach
in women with suspicion on CP.
Before discussing possible explanations of the absence
of pneumothorax relapse in the absence of postoperative
hormonal therapy, some terminological clarifications
should be given.
First, with the increased recognition of this disease,
some confusion in the literature appeared due to the
observation that in some women, pneumothorax, pre-
ceding or occurring immediately after the menses, was
associated with intrathoracic endometriosis. So, from the
clinical standpoint, all patients, reported under the com-
mon diagnosis of “catamenial pneumothorax”, could be
divided in two groups: the first, including women in
whom pneumothoraces have some temporal relation
menses, and in whom proven diaphragmatic defects
exist with or without endometriosis; the second group
relates to so called, endometriosis-related, non-catamenial
pneumothorax, ie. pneumothorax with proven intratho-
racic endometriosis, with or without diaphragmatic
defects, but without temporal relationship with menses
[10]. Second, some authors accept the diagnosis of
thoracic endometriosis only if both endometrial stroma
and glands are found at histology of the lesions, and
define it as “probable” when only stroma is found [11].
Our case-series, although limited, confirms the rele-
vance of the aforementioned considerations. This because
the first patient had a so called “confirmed” endometriosis,
with both stroma and glands, whilst in the second patient
the pathological report was highly suggestive of endomet-
riosis, with clear endometrial stroma, but without glands.
In the third patients, even in the absence of macroscopic
signs of endometriosis in the vicinity of the diaphragmatic
defects, it is not possible to rule it out with certainty, be-
cause the diaphragm plication was done without removing
of the affected part of the diaphragm for patohistological
analysis. In the fourth patient, all the SP episodes
coincided with menses, whilst a big diaphragmatic
defect, responsible for the absence of eventual pre-
existing endometrial implants, was surrounded by
small diaphragm defects, typical for CP. Those are
key-arguments against the possibility of spontaneous
diaphragmatic rupture in this patient, reported so far
only 28 times in the English literature and being left
sided in 68 % of patients [12].
The morphology of the diaphragmatic defects in
patients 1–3 corresponded to those most frequently
reported, in a form of holes measuring 1–3 milimeters
[13], rarely more than 10 mm, [14]. Larger fenestrations
(4–10 cm, or complete diaphragmatic rupture) have
been only exceptionally reported [15–17]. To the best of
our knowledge, the fourth presented patient is the fourth
case in the English literature with CP and liver hernia-
tion through the diaphragm defect.
Although not essential for diagnosis, there are some
symptoms suggestive of CP, like thoracic pain preceding
or during menstruation (pts. N0 2 and 3), symptoms of
pelvic endometriosis, like dysmenorrhea or dyspareunia.
Furthermore, history of primary or secondary infertility,
with or without diagnosis of previous pelvic endometri-
osis, history of previous gynaecologic procedure [18], in
a woman with first episode or recurrent SP should rise
suspicion of this condition. The first presented patient
confirms the literature data in a way that in case of SP
onset in the intermenstrual period, the diagnosis of
endometriosis-related pneumothorax should not be pre-
cluded, even in the absence of previous diagnosis or
symptoms of pelvic endometriosis.
In all presented patients, age (generative period),
pneumothorax recurrence and right-sided location were
strong enough to rise suspicion of CP. Despite the fact
that the correct diagnosis was obtained, in none of them
hormonal therapy was given postoperatively. The rea-
sons for such a scenario were different: the first patient
wanted to be pregnant, whilst the second and third
Fig. 4 Diaphragm suture (patient 2)
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patients were not suggested hormonal treatment by their
gynaecologists. In fact, the rationale for postoperative
hormonal therapy - hormonal dependence of endomet-
rial implants - with the idea to have the same effect on
the pulmonary endometrial implants, could be applied
to all three patients. In the first two patients the target
tissue of the hormonal treatment would be the con-
firmed endometriosis, which, although removed by dia-
phragm resection, might have persisted in the vicinity or
in the lungs, where they may be easily overlooked. In the
third patient, even without confirmed endometriosis,
hormonal treatment could have a recurrence prevention
effect through preventing a passage of the air from the
abdomen through tiny holes in the diaphragm in the
diaphragm plication area.
It can only be speculated how long the presented pa-
tients will remain SP recurrence-free, having in mind the
much higher incidence of SP recurrences in patients
with catamenial vs. non-catamenial SP (32 % vs. 5.3 %)
as mirrored in the experience of Alifano et al. (ref. 11).
Furthermore, even postoperative recurrence rate re-
mains quite high, as reported by Visouli (2012), Leong
(2006), Marshall (2005), and Ciriaco (2009) with recur-
rence rates being 20 %, 25 %, 27,5 % and 40 %, respect-
ively, during a follow up of 34–52 months [19, 20].
However, in almost all patients, recurrences occurred in
patients in whom hormonal therapy was omitted or was
due to be commenced. In only one series, it was not
clear whether the recurrence occurred because of the
absence of hormonal treatment or because of the under-
estimation of the tiny diaphragmatic holes that remained
untreated.
Gonadotropin-releasing hormone agonists produce a
hypogonadotrophic-hypogonadic state by downregula-
tion of the pituitary gland. The treatment is restricted to
6 months, because side effects, mostly loss of trabecular
bone density, hot flashes and vaginal dryness. The bone
density is usually restored 2 years after treatment cessa-
tion [21, 22]. However, unlike the widely accepted period
of six months of hormonal treatment as sufficient to
avoid recurrences [23], there are no data about the bene-
fit of this kind of treatment if initiated after more than
6 months or later after the operation. As presented,
although none of our patients underwent a postoperative
hormonal treatment, no pneumothorax recurrences were
registered during a follow up of 18, 36 and 8 months. The
follow up of our patients was equal or only slightly shorter
than usually reported.
Conclusion
Although not arguing against the benefit of routine post-
operative hormonal therapy in all women with CP, our
experience suggests that such a policy should be recon-
sidered and re-evaluated in further studies.
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